Effects of a single dose levodopa on heart rate variability in Parkinson's disease

Lingqiu Meng, Erika M Driver-Dunckley, Xiaolin Xu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: To explore the effects of levodopa on heart rate variability (HRV) in Parkinson's disease (PD).

METHODS: A total of 48 PD patients (M:F = 35: 13, mean age: 59 ± 6 years, duration of illness: 4.7 ± 1.8 years, Hoehn & Yahr stage: 2.2 ± 0.3) on a stable dose of levodopa were recruited from January 2012 to May 2014.For confirming autonomic dysfunction, the baseline patient data (12 hours off-medication) were compared with a control group consisting of 48 age and gender-matched healthy subjects (M: F = 35: 13, mean age 58 ± 6 years). Resting lead II electrocardiogram (ECG) was recorded at baseline and continuously after two tablets of 100/10 mg levodopa/carbidopa.However, 5-min segments were selected from every quarter, i.e., Q1 (0-15 min), Q2 (15-30 min), Q3 (30-45 min) and Q4 (45-60 min). Artifact-free 5-min segments of ECG were analyzed offline to acquire the parameters of heart rate variability in time and frequency domains.

RESULTS: At baseline, PD patients had a significantly reduced standard deviation of normal-to-normal intervals (SDRR) [(24 ± 4) vs (26 ± 4) ms, P < 0.01)] and total power (TP) [(569 ± 180) vs (652 ± 205) ms², P < 0.05] when compared to controls. Comparing of HRV in PD patients at baseline and during first hour after drug administration, we observed significant increase in SDRR [(29 ± 12) vs (24 ± 8) ms, P < 0.05)], TP [(708 ± 253) vs (569 ± 180) ms², P < 0.01], low frequency power (LF) [(203 ± 98) vs (168 ± 60) ms², P < 0.05) ] and high frequency power (HF) [158 ± 86) vs (114 ± 90) ms², P < 0.05] in Q3.

CONCLUSION: The results suggest an improvement in the overall variability of heart rate resulting from an enhanced vagal tone.

Original languageEnglish (US)
Pages (from-to)493-495
Number of pages3
JournalZhonghua yi xue za zhi
Volume95
Issue number7
StatePublished - Feb 17 2015

Fingerprint

Levodopa
Parkinson Disease
Heart Rate
Electrocardiography
Artifacts
Tablets
Healthy Volunteers
Control Groups
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effects of a single dose levodopa on heart rate variability in Parkinson's disease. / Meng, Lingqiu; Driver-Dunckley, Erika M; Xu, Xiaolin.

In: Zhonghua yi xue za zhi, Vol. 95, No. 7, 17.02.2015, p. 493-495.

Research output: Contribution to journalArticle

@article{4dbe895a49fe48faafc74195021cbb84,
title = "Effects of a single dose levodopa on heart rate variability in Parkinson's disease",
abstract = "OBJECTIVE: To explore the effects of levodopa on heart rate variability (HRV) in Parkinson's disease (PD).METHODS: A total of 48 PD patients (M:F = 35: 13, mean age: 59 ± 6 years, duration of illness: 4.7 ± 1.8 years, Hoehn & Yahr stage: 2.2 ± 0.3) on a stable dose of levodopa were recruited from January 2012 to May 2014.For confirming autonomic dysfunction, the baseline patient data (12 hours off-medication) were compared with a control group consisting of 48 age and gender-matched healthy subjects (M: F = 35: 13, mean age 58 ± 6 years). Resting lead II electrocardiogram (ECG) was recorded at baseline and continuously after two tablets of 100/10 mg levodopa/carbidopa.However, 5-min segments were selected from every quarter, i.e., Q1 (0-15 min), Q2 (15-30 min), Q3 (30-45 min) and Q4 (45-60 min). Artifact-free 5-min segments of ECG were analyzed offline to acquire the parameters of heart rate variability in time and frequency domains.RESULTS: At baseline, PD patients had a significantly reduced standard deviation of normal-to-normal intervals (SDRR) [(24 ± 4) vs (26 ± 4) ms, P < 0.01)] and total power (TP) [(569 ± 180) vs (652 ± 205) ms², P < 0.05] when compared to controls. Comparing of HRV in PD patients at baseline and during first hour after drug administration, we observed significant increase in SDRR [(29 ± 12) vs (24 ± 8) ms, P < 0.05)], TP [(708 ± 253) vs (569 ± 180) ms², P < 0.01], low frequency power (LF) [(203 ± 98) vs (168 ± 60) ms², P < 0.05) ] and high frequency power (HF) [158 ± 86) vs (114 ± 90) ms², P < 0.05] in Q3.CONCLUSION: The results suggest an improvement in the overall variability of heart rate resulting from an enhanced vagal tone.",
author = "Lingqiu Meng and Driver-Dunckley, {Erika M} and Xiaolin Xu",
year = "2015",
month = "2",
day = "17",
language = "English (US)",
volume = "95",
pages = "493--495",
journal = "National Medical Journal of China",
issn = "0376-2491",
publisher = "Zhonghua Yixuehui Zazhishe",
number = "7",

}

TY - JOUR

T1 - Effects of a single dose levodopa on heart rate variability in Parkinson's disease

AU - Meng, Lingqiu

AU - Driver-Dunckley, Erika M

AU - Xu, Xiaolin

PY - 2015/2/17

Y1 - 2015/2/17

N2 - OBJECTIVE: To explore the effects of levodopa on heart rate variability (HRV) in Parkinson's disease (PD).METHODS: A total of 48 PD patients (M:F = 35: 13, mean age: 59 ± 6 years, duration of illness: 4.7 ± 1.8 years, Hoehn & Yahr stage: 2.2 ± 0.3) on a stable dose of levodopa were recruited from January 2012 to May 2014.For confirming autonomic dysfunction, the baseline patient data (12 hours off-medication) were compared with a control group consisting of 48 age and gender-matched healthy subjects (M: F = 35: 13, mean age 58 ± 6 years). Resting lead II electrocardiogram (ECG) was recorded at baseline and continuously after two tablets of 100/10 mg levodopa/carbidopa.However, 5-min segments were selected from every quarter, i.e., Q1 (0-15 min), Q2 (15-30 min), Q3 (30-45 min) and Q4 (45-60 min). Artifact-free 5-min segments of ECG were analyzed offline to acquire the parameters of heart rate variability in time and frequency domains.RESULTS: At baseline, PD patients had a significantly reduced standard deviation of normal-to-normal intervals (SDRR) [(24 ± 4) vs (26 ± 4) ms, P < 0.01)] and total power (TP) [(569 ± 180) vs (652 ± 205) ms², P < 0.05] when compared to controls. Comparing of HRV in PD patients at baseline and during first hour after drug administration, we observed significant increase in SDRR [(29 ± 12) vs (24 ± 8) ms, P < 0.05)], TP [(708 ± 253) vs (569 ± 180) ms², P < 0.01], low frequency power (LF) [(203 ± 98) vs (168 ± 60) ms², P < 0.05) ] and high frequency power (HF) [158 ± 86) vs (114 ± 90) ms², P < 0.05] in Q3.CONCLUSION: The results suggest an improvement in the overall variability of heart rate resulting from an enhanced vagal tone.

AB - OBJECTIVE: To explore the effects of levodopa on heart rate variability (HRV) in Parkinson's disease (PD).METHODS: A total of 48 PD patients (M:F = 35: 13, mean age: 59 ± 6 years, duration of illness: 4.7 ± 1.8 years, Hoehn & Yahr stage: 2.2 ± 0.3) on a stable dose of levodopa were recruited from January 2012 to May 2014.For confirming autonomic dysfunction, the baseline patient data (12 hours off-medication) were compared with a control group consisting of 48 age and gender-matched healthy subjects (M: F = 35: 13, mean age 58 ± 6 years). Resting lead II electrocardiogram (ECG) was recorded at baseline and continuously after two tablets of 100/10 mg levodopa/carbidopa.However, 5-min segments were selected from every quarter, i.e., Q1 (0-15 min), Q2 (15-30 min), Q3 (30-45 min) and Q4 (45-60 min). Artifact-free 5-min segments of ECG were analyzed offline to acquire the parameters of heart rate variability in time and frequency domains.RESULTS: At baseline, PD patients had a significantly reduced standard deviation of normal-to-normal intervals (SDRR) [(24 ± 4) vs (26 ± 4) ms, P < 0.01)] and total power (TP) [(569 ± 180) vs (652 ± 205) ms², P < 0.05] when compared to controls. Comparing of HRV in PD patients at baseline and during first hour after drug administration, we observed significant increase in SDRR [(29 ± 12) vs (24 ± 8) ms, P < 0.05)], TP [(708 ± 253) vs (569 ± 180) ms², P < 0.01], low frequency power (LF) [(203 ± 98) vs (168 ± 60) ms², P < 0.05) ] and high frequency power (HF) [158 ± 86) vs (114 ± 90) ms², P < 0.05] in Q3.CONCLUSION: The results suggest an improvement in the overall variability of heart rate resulting from an enhanced vagal tone.

UR - http://www.scopus.com/inward/record.url?scp=84964695083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964695083&partnerID=8YFLogxK

M3 - Article

C2 - 25916922

AN - SCOPUS:84964695083

VL - 95

SP - 493

EP - 495

JO - National Medical Journal of China

JF - National Medical Journal of China

SN - 0376-2491

IS - 7

ER -